Management of refractory pruritus with difelikefalin in a patient on incremental hemodialysis one day a week: Is it safe and effective?

被引：0
|
作者：
de la Flora, Jose C. [1 ]
Cruzadob, Leonidas [2 ]
Deirac, Javier [3 ]
Valgad, Francisco [4 ]
Sualdeaa, Beatriz [1 ]
Zamorae, Rocio [5 ]
Rodeles, Miguel [1 ]
机构：
[1] Hosp Cent Def Gomez Ulla, Serv Nefrol, Madrid, Spain
[2] Hosp Gen Elche, Serv Nefrol, Alicante, Spain
[3] Hosp San Pedro Alcantara, Serv Nefrol, Caceres, Spain
[4] Hosp Univ Dr Negrin, Serv Nefrol, Las Palmas Gran Canaria, Spain
[5] Hosp Univ Gen Villalba, Serv Nefrol, Madrid, Spain
来源：
NEFROLOGIA | 2024年 / 44卷 / 03期
关键词：
D O I：
10.1016/j.nefro.2023.07.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 439
页数：3
相关论文
共 50 条
  • [21] Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients
    F. J. Peñalver
    V. Jimenez-Yuste
    M. Almagro
    A. Alvarez-Larrán
    L. Rodríguez
    M. Casado
    L. Gallur
    P. Giraldo
    R. Hernández
    D. Menor
    M. J. Rodríguez
    D. Caballero
    R. González
    J. Mayans
    I. Millán
    J. R. Cabrera
    Annals of Hematology, 2006, 85 : 558 - 558
  • [22] Low dose sacubitril/valsartan is effective and safe in hemodialysis patient with decompensated heart failure and hypotension A case report
    Feng, Yunlin
    Li, Wenhua
    Liu, Hongjun
    Chen, Xiuling
    MEDICINE, 2022, 101 (15) : E29186
  • [23] One Hour Fast for Liquids Prior to Endoscopy Is Safe, Effective and Results in Minimum Patient Discomfort
    De Silva, Arjuna P.
    Amarasiri, Lakmali A.
    Kottahachchi, Dulani C.
    Sabhapathige, Ranga D.
    Dassanayake, Anuradha S.
    De Silva, Janaka H.
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB194 - AB194
  • [24] One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma
    Moatti, H.
    Brice, P.
    Laroque, M-C
    Di Blasi, R.
    Wencel, J.
    Delory, T.
    Madelaine-Chambrin, I.
    Schmidt-Hieber, C.
    Ravdan, O.
    Thieblemont, C.
    Renaud, L.
    HEMATOLOGICAL ONCOLOGY, 2025, 43 (01)
  • [25] Therapeutic paracentesis on demand by nurse practitioner: A safe and cost-effective approach to management of refractory ascites.
    Williams, LM
    Gilles, HS
    Mihas, AA
    Abou Assi, S
    Heuman, DM
    HEPATOLOGY, 2001, 34 (04) : 545A - 545A
  • [26] Definitive Laparoscopic Roux-en-Y Oesophagojejunostomy - A Safe and Effective Management Option for Refractory Sleeve Leak
    Ilczyszyn, Andrei
    Mok, Jessica
    Zakeri, Roxana
    Fakih-Gomez, Naim
    Elkalaawy, Mohammed
    Jenkinson, Andrew
    Adamo, Marco
    OBESITY SURGERY, 2019, 29 : S13 - S14
  • [27] SAFE, EFFECTIVE, PATIENT-CENTRED MANAGEMENT OF MALIGNANT HYPERTENSION IN AN AMBULATORY SETTING: A CASE REPORT
    Shayan-Arani, Holleh
    Chapman, Neil
    Janmohamed, Azara
    JOURNAL OF HUMAN HYPERTENSION, 2023, 37 : 36 - 36
  • [28] Thrombocytopenia in a Hemodialysis Patient Starting Home Therapy with NxStage System One: Management in a Community Setting
    Parmar, Malvinder
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2021, 32 (06) : 1775 - 1781
  • [29] Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
    Martinez-Montiel, M.
    Piedracoba-Cadahia, Pilar
    Gomez-Gomez, Carlos
    Gonzalo, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (09): : 816 - 817
  • [30] One hour Rituximab infusion is safe and improves patient care and outpatient unit management.
    Aurran-Schleinitz, T
    Gravis, G
    Vittot, M
    Coso, D
    Rey, J
    Schiano, JM
    Charbonnier, A
    Fougereau, E
    Maraninchi, D
    Bouabdallah, R
    BLOOD, 2005, 106 (11) : 270B - 270B
12345